Acadia Healthcare prices $550 million 7.375% senior notes due 2033
Acadia Healthcare Company entered into an indenture dated March 10, 2025 for $550 million of 7.375% senior unsecured notes maturing March 15, 2033, sold in a private offering to qualified institutional and non-U.S. buyers. The company said it will use the proceeds to prepay outstanding borrowings under its senior secured revolving line of credit, which replaces floating-rate revolver debt with fixed-rate notes and adds $550 million of long-term debt to its balance sheet.
Key points
- Notes total $550 million in principal, up $50 million from the $500 million launched March 5, 2025, and were offered at 100% of principal.
- Interest of 7.375% per year is payable semi-annually on March 15 and September 15, starting September 15, 2025.
- The company may redeem the notes on or after March 15, 2028, and may redeem up to 40% before then using equity offering proceeds at 107.375% of principal.
- The indenture limits additional debt, liens, dividends, stock buybacks, asset sales and mergers, and the offering was expected to close March 10, 2025.
The filing
Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 10, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.